Literature DB >> 23231083

A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection.

R Cassini1, M S De Mitri, D Gibellini, L Urbinati, S Bagaglio, G Morsica, M Domenicali, G Verucchi, M Bernardi.   

Abstract

To characterize occult HBV infection (OHB) in different compartments of HIV+ individuals. This retrospective study involved 38 consecutive HIV+ patients; 24 HBsAg negative (HBV-) and 14 HBsAg positive (HBV+). OHB was assessed in serum samples, liver tissue (LT) and peripheral blood mononuclear cells (PBMC) by genomic amplification of the partial S, X and precore/core regions. HBV genomic analysis was inferred by direct sequencing of PCR products. The intracellular HBV-DNA was measured by a quantitative real-time PCR. HBV+ patients were used as a control for HBV replication and genomic profile. In HBV- patients, HBV-DNA was undetectable in all serum samples, while it was found positive in 7/24 (29%) LT in which genotype D prevailed (57%). HBV-DNA was found in 6/7 (86%) PBMC of occult-positive and none of occult-negative LT. Significantly lower HBV-DNA load was present in both compartments in OHB+ with respect to the HBV+ group (LT: P = 0.002; PBMC: P = 0.026). In the occult-positive cases, HBV replication was significantly higher in LT than in PBMC (P = 0.028). A hyper-mutated S gene in PBMC and a nucleotide mutation at position C695 in LT that produces a translational stop codon at amino acid 181 of the HBs gene characterized OHB. In this group of HIV+ persons, OHB is frequent and exhibits lower replication levels than chronic HBV in the different compartments examined. HBV-DNA detection in PBMC may offer a useful tool to identify OHB in serum-negative cases. The novel HBs gene stop codon found in LT could be responsible for reduced production leading to undetectability of HBsAg.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23231083     DOI: 10.1111/j.1365-2893.2012.01623.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  9 in total

Review 1.  Genetic variation of occult hepatitis B virus infection.

Authors:  Hui-Lan Zhu; Xu Li; Jun Li; Zhen-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

Review 2.  Overview of hepatitis B virus mutations and their implications in the management of infection.

Authors:  Patrizia Caligiuri; Rita Cerruti; Giancarlo Icardi; Bianca Bruzzone
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 3.  Clinical impact of occult hepatitis B virus infection in immunosuppressed patients.

Authors:  Evangelista Sagnelli; Mariantonietta Pisaturo; Salvatore Martini; Pietro Filippini; Caterina Sagnelli; Nicola Coppola
Journal:  World J Hepatol       Date:  2014-06-27

4.  Mutations associated with occult hepatitis B in HIV-positive South Africans.

Authors:  Eleanor A Powell; Maemu P Gededzha; Michael Rentz; Nare J Rakgole; Selokela G Selabe; Tebogo A Seleise; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Med Virol       Date:  2014-08-27       Impact factor: 2.327

Review 5.  Clinical implications of hepatitis B virus mutations: recent advances.

Authors:  Ivana Lazarevic
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 6.  Hepatitis B virus genetic mutations and evolution in liver diseases.

Authors:  Tao Shen; Xin-Min Yan
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

7.  Bovine viral diarrhoea virus loses quasispecies diversity rapidly in culture.

Authors:  George C Russell; Ruth N Zadoks; Kim Willoughby; Claudia Bachofen
Journal:  Microb Genom       Date:  2020-03-11

8.  Novel Genetic Variants of Hepatitis B Virus in Fulminant Hepatitis.

Authors:  Jack Bee Chook; Yun Fong Ngeow; Kok Keng Tee; Suat Cheng Peh; Rosmawati Mohamed
Journal:  J Pathog       Date:  2017-12-19

9.  Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.

Authors:  Giulia Morsica; Sabrina Bagaglio; Vincenzo Spagnuolo; Antonella Castagna; Clelia Di Serio; Andrea Galli; Liviana Della Torre; Andrea Andolina; Alexander Pramov; Caterina Uberti-Foppa
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.